[{"id":12276,"run_id":437,"as_of":"2026-09-10","ticker":"GRCE","company":"Grace Therapeutics, Inc.","source":"weekly","conviction":41.0,"technical":40.0,"stage":"No Long Regime","gated":true,"n_gates":7,"gates":["Price below the 200DMA — no long regime.","200DMA is not rising — regime not clear.","50DMA is not rising.","Overlapping range behaviour — efficiency ratio 0.02 vs the 0.15 threshold (genuine chop).","Market cap $48M below the $300M floor.","Avg dollar volume $0.30M below the liquidity floor.","Price $2.26 below the $5.00 floor."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":2.26,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":1.5,"Volatility behaviour":15.7,"Cross-asset confirmation":7.8,"Sponsorship / positioning":7.0,"Catalyst alignment (insider)":9.0},"total_cfo_value":0.0,"total_other_value":270102.0,"n_cfo_buys":0.0,"n_other_buys":3.0,"has_cfo_buy":false,"roles_buying":"1 CEO, 2 Unclassified","npr":1.0,"cluster_insiders":2.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-09-10T21:40:45.725805+00:00"},{"id":12369,"run_id":438,"as_of":"2026-09-11","ticker":"GRCE","company":"Grace Therapeutics, Inc.","source":"weekly","conviction":33.0,"technical":30.0,"stage":"No Long Regime","gated":true,"n_gates":7,"gates":["Price below the 200DMA — no long regime.","200DMA is not rising — regime not clear.","50DMA is not rising.","Overlapping range behaviour — efficiency ratio 0.00 vs the 0.15 threshold (genuine chop).","Market cap $47M below the $300M floor.","Avg dollar volume $0.36M below the liquidity floor.","Price $2.22 below the $5.00 floor."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":2.22,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":1.5,"Volatility behaviour":8.2,"Cross-asset confirmation":7.3,"Sponsorship / positioning":7.0,"Catalyst alignment (insider)":9.0},"total_cfo_value":0.0,"total_other_value":270102.0,"n_cfo_buys":0.0,"n_other_buys":3.0,"has_cfo_buy":false,"roles_buying":"1 CEO, 2 Unclassified","npr":1.0,"cluster_insiders":2.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-09-11T21:13:17.292546+00:00"},{"id":12982,"run_id":440,"as_of":"2026-09-14","ticker":"GRCE","company":"Grace Therapeutics, Inc.","source":"weekly","conviction":33.8,"technical":31.0,"stage":"No Long Regime","gated":true,"n_gates":7,"gates":["Price below the 200DMA — no long regime.","200DMA is not rising — regime not clear.","50DMA is not rising.","Overlapping range behaviour — efficiency ratio 0.03 vs the 0.15 threshold (genuine chop).","Market cap $48M below the $300M floor.","Avg dollar volume $0.33M below the liquidity floor.","Price $2.29 below the $5.00 floor."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":2.29,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":1.5,"Volatility behaviour":8.2,"Cross-asset confirmation":8.1,"Sponsorship / positioning":7.0,"Catalyst alignment (insider)":9.0},"total_cfo_value":0.0,"total_other_value":270102.0,"n_cfo_buys":0.0,"n_other_buys":3.0,"has_cfo_buy":false,"roles_buying":"1 CEO, 2 Unclassified","npr":1.0,"cluster_insiders":2.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-09-14T21:02:09.279670+00:00"},{"id":13548,"run_id":442,"as_of":"2026-09-15","ticker":"GRCE","company":"Grace Therapeutics, Inc.","source":"weekly","conviction":34.2,"technical":31.5,"stage":"No Long Regime","gated":true,"n_gates":7,"gates":["Price below the 200DMA — no long regime.","200DMA is not rising — regime not clear.","50DMA is not rising.","Overlapping range behaviour — efficiency ratio 0.06 vs the 0.15 threshold (genuine chop).","Market cap $47M below the $300M floor.","Avg dollar volume $0.32M below the liquidity floor.","Price $2.23 below the $5.00 floor."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":2.23,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":1.5,"Volatility behaviour":8.2,"Cross-asset confirmation":8.5,"Sponsorship / positioning":7.0,"Catalyst alignment (insider)":9.0},"total_cfo_value":0.0,"total_other_value":270102.0,"n_cfo_buys":0.0,"n_other_buys":3.0,"has_cfo_buy":false,"roles_buying":"1 CEO, 2 Unclassified","npr":1.0,"cluster_insiders":2.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-09-15T21:04:48.311557+00:00"},{"id":14148,"run_id":444,"as_of":"2026-09-16","ticker":"GRCE","company":"Grace Therapeutics, Inc.","source":"weekly","conviction":35.1,"technical":32.6,"stage":"No Long Regime","gated":true,"n_gates":7,"gates":["Price below the 200DMA — no long regime.","200DMA is not rising — regime not clear.","50DMA is not rising.","Overlapping range behaviour — efficiency ratio 0.05 vs the 0.15 threshold (genuine chop).","Market cap $45M below the $300M floor.","Avg dollar volume $0.32M below the liquidity floor.","Price $2.14 below the $5.00 floor."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":2.14,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":1.5,"Volatility behaviour":8.2,"Cross-asset confirmation":9.4,"Sponsorship / positioning":7.0,"Catalyst alignment (insider)":9.0},"total_cfo_value":0.0,"total_other_value":270102.0,"n_cfo_buys":0.0,"n_other_buys":3.0,"has_cfo_buy":false,"roles_buying":"1 CEO, 2 Unclassified","npr":1.0,"cluster_insiders":2.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-09-16T21:30:15.198638+00:00"},{"id":14742,"run_id":451,"as_of":"2026-09-17","ticker":"GRCE","company":"Grace Therapeutics, Inc.","source":"weekly","conviction":34.9,"technical":32.4,"stage":"No Long Regime","gated":true,"n_gates":7,"gates":["Price below the 200DMA — no long regime.","200DMA is not rising — regime not clear.","50DMA is not rising.","Overlapping range behaviour — efficiency ratio 0.11 vs the 0.15 threshold (genuine chop).","Market cap $45M below the $300M floor.","Avg dollar volume $0.31M below the liquidity floor.","Price $2.13 below the $5.00 floor."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":2.13,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":1.5,"Volatility behaviour":8.2,"Cross-asset confirmation":9.2,"Sponsorship / positioning":7.0,"Catalyst alignment (insider)":9.0},"total_cfo_value":0.0,"total_other_value":270102.0,"n_cfo_buys":0.0,"n_other_buys":3.0,"has_cfo_buy":false,"roles_buying":"1 CEO, 2 Unclassified","npr":1.0,"cluster_insiders":2.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-09-17T21:06:22.295534+00:00"},{"id":15351,"run_id":455,"as_of":"2026-10-14","ticker":"GRCE","company":"Grace Therapeutics, Inc.","source":"weekly","conviction":30.5,"technical":26.9,"stage":"No Long Regime","gated":true,"n_gates":6,"gates":["Price below the 200DMA — no long regime.","200DMA is not rising — regime not clear.","50DMA is not rising.","Market cap $40M below the $300M floor.","Avg dollar volume $0.21M below the liquidity floor.","Price $1.89 below the $5.00 floor."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":1.89,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":3.2,"Volatility behaviour":11.3,"Cross-asset confirmation":0.0,"Sponsorship / positioning":7.0,"Catalyst alignment (insider)":9.0},"total_cfo_value":0.0,"total_other_value":471695.0,"n_cfo_buys":0.0,"n_other_buys":7.0,"has_cfo_buy":false,"roles_buying":"1 CEO, 6 Unclassified","npr":1.0,"cluster_insiders":2.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-10-14T21:57:05.171892+00:00"},{"id":15447,"run_id":456,"as_of":"2026-10-15","ticker":"GRCE","company":"Grace Therapeutics, Inc.","source":"weekly","conviction":43.4,"technical":43.0,"stage":"No Long Regime","gated":true,"n_gates":6,"gates":["Price below the 200DMA — no long regime.","200DMA is not rising — regime not clear.","50DMA is not rising.","Market cap $41M below the $300M floor.","Avg dollar volume $0.21M below the liquidity floor.","Price $1.95 below the $5.00 floor."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":1.95,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":2.1,"Volatility behaviour":11.3,"Cross-asset confirmation":14.0,"Sponsorship / positioning":7.0,"Catalyst alignment (insider)":9.0},"total_cfo_value":0.0,"total_other_value":471695.0,"n_cfo_buys":0.0,"n_other_buys":7.0,"has_cfo_buy":false,"roles_buying":"1 CEO, 6 Unclassified","npr":1.0,"cluster_insiders":2.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-10-15T21:13:44.615367+00:00"},{"id":16027,"run_id":458,"as_of":"2026-10-16","ticker":"GRCE","company":"Grace Therapeutics, Inc.","source":"weekly","conviction":39.7,"technical":38.4,"stage":"No Long Regime","gated":true,"n_gates":6,"gates":["Price below the 200DMA — no long regime.","200DMA is not rising — regime not clear.","50DMA is not rising.","Market cap $40M below the $300M floor.","Avg dollar volume $0.22M below the liquidity floor.","Price $1.89 below the $5.00 floor."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":1.89,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":2.4,"Volatility behaviour":7.3,"Cross-asset confirmation":14.0,"Sponsorship / positioning":7.0,"Catalyst alignment (insider)":9.0},"total_cfo_value":0.0,"total_other_value":471695.0,"n_cfo_buys":0.0,"n_other_buys":7.0,"has_cfo_buy":false,"roles_buying":"1 CEO, 6 Unclassified","npr":1.0,"cluster_insiders":2.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-10-16T20:55:56.165619+00:00"}]